Next Generation Medical Technology

AC5™ stops bleeding promptly. Unlike many competitive products, it conforms to irregular wound geometry, allows for normal healing, and helps maintain a clear field of vision.

Learn More


Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care.

Learn More ›


The hemostasis market is clearly in search of products that work better, faster, & more reliably. The AC5 Surgical Hemostatic Device™ is designed to do that.

Learn More ›


The management team possesses proven science and business track records with the knowledge to build, run and grow a commercial enterprise.

Learn More ›


The AC5 Surgical Hemostatic Device™ value proposition is based on the premise of faster and safer surgery. The product is designed to be simple, effective, versatile, and safe.

Learn More

Surgical Procedures with Potential for the use of Hemostats, Sealants, Glues and Adhesion Prevention Products, Worldwide (Millions). 2011

(Source: MedMarket Diligence, LLC; "Surgical Sealants, Glues Worldwide.")

Company Video

Arch Therapeutics, Inc. is a medical device company offering an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care.

Play Video